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participate to databases will certainly decrease the average 
quality of the data and consequently aggravate the risks. 
Therefore, participation to databases should not be made 
mandatory.  
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Rational: Radiation oncology is very sensitive to quality 
assurances due to its specificity: different tumours, various 
patients, multiple sequences of treatment with high tech 
machines and information systems. Obtaining the best results 
as possible does imply a quality control of the equipment 
(machines…), of the professionals (certification), of the 
organisations (audits, accreditation) and finally of the 
treatment itself (clinical validation). The key point is to have 
indicators able to give a robust evaluation on quality 
parameters. 
Material and methods: A quality policy is based on 3 steps: 
description of Standard operation procedures (SOP’s), 
consideration of Human factors (Radiotherapy Resource 
Management) and implementation of “feed back “committee. 
Developing indicators for every step is critical to evaluate in 
time and compare QA policies. However, the most 
challenging step remains the evaluation of treatment 
outcome itself. 
Results: Quality of care is mostly depending on individuals 
but on the contrary, indicators must be independent of 
human appreciation and valid for all organizations and 
processes. Side to the classical ones (accidents, incidents, 
near misses...), treatment results must be taken into 
consideration. Prospective data base mining  as well as 
patients related outcomes (PRO’s), independent of the care 
professionals, may be the most valuable indicators to be 
considered in the near future. 
Conclusion : Quality is critical in “good medical practice”. 
The evaluation of results (audits, publications...) remains the 
gold standard and will be mostly patient dependent in the 
near future. 
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Synopsis: The ASTRO Accreditation Program for Excellence 
(APEx™) provides the opportunity to build upon and integrate 
ASTRO’s quality improvement initiatives. Findings from APEx 
will potentially highlight variances in the delivery of radiation 
oncology care, inform educational offerings, and identify 
topics for clinical practice statements and quality measures 
development. APEx was created to encourage accountability 
in radiation therapy practices. The program establishes 
standards of performance derived from white papers and 
consensus practice guidance for radiation oncology. Facilities 
that obtain practice accreditation will have the systems, 
personnel, and policies and procedures that are needed to 
meet the APEx standards for high-quality, safe patient care. 
 The mission of the APEx is to recognize facilities by 
objectively assessing the radiation oncology care team, 
policies and procedures, and the facility. APEx provides an 
objective review by professional peers of essential functions 
and processes of radiation oncology practices. It offers 
transparent, measurable, evidence- and consensus-based 
standards that emphasize a professional commitment to 
safety and quality. Radiation oncology practices accredited 
by ASTRO will: 
• Undergo an objective, external review of radiation 
oncology programs, policies and processes; 
• Demonstrate respect for protecting the rights of patients 
and responsiveness to patient needs and concerns; and 
• Adopt cutting edge procedures to encourage safety and 
quality of care. 
  
The standards reflect competencies and practices identified 
and endorsed in the publication, Safety is No Accident: A 
Framework for Quality Radiation Oncology and Care. This 
framework provides guidance for essential practices in 
radiation oncology. It describes a multidisciplinary approach 
to care that focuses on quality measurement to encourage 
safe, effective and peer-reviewed radiation oncology care. 
The ASTRO standards translate the goals outlined by the 
Framework into objective, verifiable expectations for 
performance in radiation oncology practice. ASTRO will work 
closely with radiation oncologists, interdisciplinary radiation 
therapy professionals, consumers and payers to identify 
improved performance indicators and measures of 
accountability. Through this continuous quality improvement, 
the APEx program and its accredited facilities will be on the 
forefront of accountability and performance. 
   
SP-0328   
Report on the ESTRO task group on Quality management in 
radiation therapy 
C. Ceberg1, E. Fallon2, M. Guckenberger3, K. Herlevin4, N. 
Jornet5, T. Knöös6, P. Nilsson6, M. Tomsej7, A. Vaandering8 
1Lund University, Medical Radiation Physics, Lund, Sweden  
2National University of Ireland, Mechanical Engineering, 
Galway, Ireland Republic of  
3University of Zurich, Radiation Oncology, Zurich, 
Switzerland  
4Centre Alexis Vautrin, Radiation Physics, Nancy, France  
5Hospital de la Santa Creu i Sant Pau, Radiophysics and 
Radioprotection, Barcelona, Spain  
6Skåne University Hospital, Radiation Physics, Lund, Sweden  
7CHU Charleroi, Medical Physics, Charleroi, Belgium  
8UCL St-Luc University Hospital, Radiation Oncology, 
Brussels, Belgium  
   
During the last decades, the evolution of radiotherapy has 
been associated with a remarkable development of high 
technology treatment equipment, advanced imaging 
techniques, and sophisticated treatment planning systems. As 
a consequence of the high complexity of today’s 
radiotherapy, extensive efforts are spent on quality controls 
in order to guarantee accurate and safe treatments. 
However, the aim of modern quality management is to go 
beyond compliance, and to continuously improve the quality 
of the treatments. In this situation, it is highly desirable to 
consider alternative options and to search for ways to use 
limited time and resources more efficiently. 
The purpose of the present ESTRO task group on quality 
management is therefore to review methods used in 
industrial processes, and to survey the current use of such 
tools in radiotherapy. For this purpose, questionnaires have 
been sent out to clinical radiotherapy and medical physics 
departments throughout Europe in order to collect 
information regarding present quality management practice. 
